Cytomegalovirus resistance in transplant patients Review
<p>CMV is a major cause of disease and mortality in patients undergoing Solid Organ Transplants (SOT) and Hematopoietic Stem Cell Transplants (HSCT). In SOT, CMV infection usually establishes itself in the first three months after transplantation in patients who do not receive prophylaxis.<...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | 図書 |
| 出版事項: |
Global Journal of Clinical Virology - Peertechz Publications,
2023-10-19.
|
| 主題: | |
| オンライン･アクセス: | Connect to this object online. |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
| 要約: | <p>CMV is a major cause of disease and mortality in patients undergoing Solid Organ Transplants (SOT) and Hematopoietic Stem Cell Transplants (HSCT). In SOT, CMV infection usually establishes itself in the first three months after transplantation in patients who do not receive prophylaxis.</p> |
|---|---|
| DOI: | 10.17352/gjcv.000013 |